Researchers at Stony Brook University have developed a powerful new painkiller that is said to possess no apparent side effects or addictive qualities could be available for purchase within the next year or two. At present, this miracle drug is in Phase II clinical trials in England and Canada.A painkiller or analgesic is any member of the group of drugs used to relieve pain. The term analgesic is derived from Greek “an”, meaning without, and “algos”, meaning pain. These drugs include paracetamol (better known as acetaminophen), non-steroidal anti-inflammatory drugs (NSAIDs), and opioids such as morphine and opium. Commonly prescribed painkillers include OxyContin, Vicodin, Methadone, Darvocet, Lortab, Lorcet and Percocet, all of which cause dependence.During the ‘90s, Dr. Simon Halegoua, Professor of Neurobiology